Gallery

Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial

Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., June 30, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals to Webcast Live at Life Sciences Investor Forum

Diffusion Pharmaceuticals to Webcast Live at Life Sciences Investor Forum 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., June 21, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Reminds Stockholders to Vote Shares In Advance of Annual Meeting

Diffusion Pharmaceuticals Reminds Stockholders to Vote Shares In Advance of Annual Meeting 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., June 18, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Reports Final Results from Its Phase 1b Study of Trans Sodium Crocetinate in Hospitalized COVID-19 Patients

Diffusion Pharmaceuticals Reports Final Results from Its Phase 1b Study of Trans Sodium Crocetinate in Hospitalized COVID-19 Patients 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., May 10, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study

Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., March 25, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Doses First Participants in TCOM Study

Diffusion Pharmaceuticals Doses First Participants in TCOM Study 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., March 18, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update

Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., March 17, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares of Common Stock

Diffusion Pharmaceuticals Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares of Common Stock 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., February 18, 2021 — Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Announces Closing of $30 Million Bought Deal Offering of Common Stock

Diffusion Pharmaceuticals Announces Closing of $30 Million Bought Deal Offering of Common Stock 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., February 17, 2021 — Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients

Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients 2560 1707 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., Feb. 16, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc.

Back to top